Matt van de Ven

Chief Operating Officer @Macumira

Toronto, ON, CA

I am thrilled to join MacuMira Medical Devices as Chief Operating Officer!As the first Health Canada-approved treatment for Dry AMD, MacuMira is poised to make a global impact, with regulatory progress already underway in additional international markets. This represents an important effort to expand access and support the millions of patients affected worldwide. I am excited to lead this journey!Microcurrent therapy, the foundation of MacuMira’s treatment, represents a novel approach to tackling this challenging condition. While its potential has already garnered regulatory recognition, I firmly believe in the importance of continued investment in robust, multi-centered research and building meaningful partnerships within the eye care community. Leveraging the expertise of ophthalmology, we can ensure the highest standards of safety, efficacy, and patient outcomes.I want to thank the team at MacuMira for their confidence in me as we chart this ambitious path forward. To my colleagues in the field of eye care—let’s embrace this opportunity to collaborate, innovate, and ultimately improve the lives of those living with Dry AMD.Here’s to advancing the future of eye care, together.#DryAMD #EyeCareInnovation #Ophthalmology #Optometry #MacuMira